Literature DB >> 30917019

Percutaneous Microwave Ablation and Cementoplasty: Clinical Utility in the Treatment of Painful Extraspinal Osseous Metastatic Disease and Myeloma.

Gerard Deib1,2,3, Benyamin Deldar1,2,3, Ferdinand Hui1,2,3, Jennifer S Barr1,2,3, Majid A Khan1,2,3.   

Abstract

OBJECTIVE: The purpose of this study was to review the efficacy and durability of pain control and local tumor control using microwave ablation and cementoplasty in treating extraspinal osseous tumors. Painful osseous metastases are a common cause of cancer-related morbidity. Percutaneous thermal ablation presents an attractive minimally invasive option in this vulnerable patient group.
MATERIALS AND METHODS: A retrospective review included 65 patients (35 men, 30 women) with 77 tumors who underwent image-guided microwave ablation and cementoplasty at a tertiary referral academic center over 18 months. Procedural efficacy was determined with a visual analog scale before the procedure and 24 hours, 2-4 weeks, and 20-24 weeks after the procedure. Locoregional control was assessed at follow-up cross-sectional imaging.
RESULTS: The 77 tumors were in the following locations: ilium, 38; acetabulum on supraacetabular region, 23; femur, five; humerus, four; shoulder, four; sternum, three. The tumors were 15 multiple myelomas and metastases from cancers of the following organs: colon, nine; lung, 15; breast, 12; thyroid, seven; prostate, three; and kidney, four. Complete, successful ablation of all 77 tumors was achieved. Mean ablation time was six minutes 15 seconds (SD, 12 seconds), and mean energy used was 5.49 (SD, 2.97) kJ. The mean visual analog scale scores were 6.32 (SD, 1.94) before the procedure, 1.01 (SD, 1.24) at 24 hours, 1.71 (SD, 1.31) at 2-4 weeks, and 2.01 (SD, 1.42) at 20-24 weeks. Follow-up imaging at 20-24 weeks showed no local progression in 42 of 65 patients (64.6%). Six patients died 24-52 weeks after the procedure. No procedure-related complications were reported.
CONCLUSION: Microwave ablation is efficacious in alleviating pain due to osseous metastases. The modality has promise for locoregional control of metastases, particularly in the context of oligometastatic (limited disseminated) disease.

Entities:  

Keywords:  bone metastasis; cementoplasty; interventional; microwave ablation; multiple myeloma; spine

Year:  2019        PMID: 30917019     DOI: 10.2214/AJR.18.20386

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

Review 1.  The Role of Ablation in Cancer Pain Relief.

Authors:  Dimitrios K Filippiadis; Steven Yevich; Frederic Deschamps; Jack W Jennings; Sean Tutton; Alexis Kelekis
Journal:  Curr Oncol Rep       Date:  2019-11-25       Impact factor: 5.075

Review 2.  Interventional Techniques for the Ablation and Augmentation of Extraspinal Lytic Bone Metastases.

Authors:  Osman Ahmed; Nicholas Feinberg; William B Lea
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

Review 3.  Interventional Palliation of Painful Extraspinal Musculoskeletal Metastases.

Authors:  Anderanik Tomasian; Jack W Jennings
Journal:  Semin Intervent Radiol       Date:  2022-06-30       Impact factor: 1.780

Review 4.  Minimally Invasive Interventional Procedures for Metastatic Bone Disease: A Comprehensive Review.

Authors:  Nicolas Papalexis; Anna Parmeggiani; Giuliano Peta; Paolo Spinnato; Marco Miceli; Giancarlo Facchini
Journal:  Curr Oncol       Date:  2022-06-07       Impact factor: 3.109

5.  The effects of combined microwave ablation and open surgery for the treatment of lung cancer-derived thoracolumbar metastases.

Authors:  Guoqing Zhong; Longhui Zeng; Yue He; Xiaolong Zeng; Wenhan Huang; Tao Yang; Xiao Chu; Jin Xiao; Dong Yin; Yunbing Chang; Shi Cheng; Yu Zhang
Journal:  Orthop Surg       Date:  2022-05-23       Impact factor: 2.279

Review 6.  Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors.

Authors:  Arian Mansur; Tushar Garg; Apurva Shrigiriwar; Vahid Etezadi; Christos Georgiades; Peiman Habibollahi; Timothy C Huber; Juan C Camacho; Sherif G Nour; Alan Alper Sag; John David Prologo; Nariman Nezami
Journal:  Diagnostics (Basel)       Date:  2022-05-24

Review 7.  Percutaneous Management of Cancer Pain.

Authors:  Dimitrios K Filippiadis; Lambros Tselikas; Alberto Bazzocchi; Evegnia Efthymiou; Alexis Kelekis; Steven Yevich
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

8.  Artificial pneumothorax improves radiofrequency ablation of pulmonary metastases of hepatocellular carcinoma close to mediastinum.

Authors:  Taiyang Zuo; Wenli Lin; Fengyong Liu; Jinshun Xu
Journal:  BMC Cancer       Date:  2021-05-06       Impact factor: 4.430

9.  Use of percutaneous microwave ablation for the treatment of bone tumors: a retrospective study of clinical outcomes in 47 patients.

Authors:  Min-Hao Wu; Ling-Fei Xiao; Fei-Fei Yan; Shi-Liang Chen; Chong Zhang; Jun Lei; Zhou-Ming Deng
Journal:  Cancer Imaging       Date:  2019-12-18       Impact factor: 3.909

10.  Continuous versus pulsed microwave ablation in the liver: any difference in intraoperative pain scores?

Authors:  Dimitrios Filippiadis; Argyro Mazioti; George Velonakis; Athanasios Tsochantzis; Nevio Tosoratti; Alexis Kelekis; Nikolaos Kelekis
Journal:  Ann Gastroenterol       Date:  2020-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.